Key result
Higher LDL-C is linked to adverse vascular phenotypes including higher pulse wave velocity, unlike BMI.
Why the study?
BMI contributes to estimated HF risk in the PREVENT-HF equation whereas cholesterol does not, prompting examination of how BMI and LDL-C relate to calculated risk and measured vascular phenotypes in treated hypertension.
Cross-Sectional (n=158)
In adults with treated hypertension without recorded CVD or HF, higher LDL-C is significantly associated with adverse subclinical vascular phenotypes despite not being included in the PREVENT-HF risk equation, whereas BMI shows no significant correlation with measured vascular markers after correction.
Answers are grounded in this paper and cite their sources.
LDL-C links to adverse vascular phenotypes in treated hypertension independent of PREVENT-HF estimates; leaves open whether cholesterol refines HF risk equations.
Background/Objectives: Body mass index (BMI) contributes to estimated heart failure (HF) risk in the Predicting Risk of cardiovascular disease EVENTs (PREVENT) HF equation, whereas cholesterol does not. We examined BMI and low-density lipoprotein cholesterol (LDL-C) associations with calculated risk and measured vascular phenotypes. Methods: This cross-sectional analysis included 158 adults with treated hypertension and no recorded cardiovascular disease or HF. Mutually adjusted models examined seven vascular, renal and inflammatory markers, with robust standard errors and false discovery rate correction across 14 comparisons. Mathematical input-variable substitution scenarios described equation behaviour. Results: Median calculated 10-year HF risk was 4.55% (interquartile range 2.52–8.39%); 44.3% had estimates ≥ 5%. Risk did not differ significantly across BMI categories (p = 0.173). Per 30 mg/dL higher LDL-C, carotid–femoral pulse wave velocity was 0.307 m/s higher, common carotid artery intima–media thickness 0.026 mm higher, flow-mediated dilation 0.277 percentage points lower, reactive hyperaemia index 0.087 lower and capillary density 0.160 loops/mm lower (all q ≤ 0.043). No BMI association passed correction. LDL-C was not significantly correlated with calculated risk after age/sex adjustment (partial ρ = 0.059; p = 0.462). Substituting BMI 25 kg/m2 lowered aggregate calculated risk by 15.0% in obesity, reflecting equation structure. Conclusions: LDL-C was associated with adverse measured vascular phenotypes. These exploratory associations do not demonstrate causality, incremental HF prediction or treatment benefit. Null BMI findings do not exclude adiposity-related vascular effects.
No takes yet. Share an insight, caveat, or question.
Craciun et al. (2026) conducted a cross-sectional in Treated hypertension (n=158). Body mass index (BMI) and low-density lipoprotein cholesterol (LDL-C) was evaluated on Calculated PREVENT-HF 10-year heart failure risk and measured vascular phenotypes (including carotid-femoral pulse wave velocity, carotid intima-media thickness, flow-mediated dilation, reactive hyperaemia index, and capillary density) (MD 0.307 m/s per 30 mg/dL higher LDL-C for carotid-femoral pulse wave velocity, p=q <= 0.043). Higher LDL-C was associated with adverse vascular phenotypes like higher pulse wave velocity, whereas BMI showed no significant associations.
Synapse has enriched 10 related papers. Consider them for comparative context: